Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Rijksinstituut voor Volksgezondheid en Milieu (RIVM)
Sponsor

Rijksinstituut voor Volksgezondheid en Milieu (RIVM)

The Netherlands Antonie Van Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands

About the sponsor

Research activity includes influenza vaccination in older adults and RSV immunisation in infants, with attention to immune responses that support protection against respiratory infection and severe disease in early life and later adulthood.

  • Influenza vaccine immunogenicity
  • RSV prevention in infants
  • Age-related vaccine response

The sponsor also examines how timing and early-life protection influence antibody development after vaccination or immunisation.

About Specializations

Rijksinstituut voor Volksgezondheid en Milieu (RIVM) runs clinical trials in conditions such as Measles immunisation, Pneumococcal immunisation, Respiratory syncytial virus infection, Respiratory syncytial virus immunisation, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

5 clinical trials

Measles immunisation

Not yet recruiting

Study on Early Measles Immunization with MMR-0 Vaccine for Infants Under 12 Months During a Measles Outbreak

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · Healthy volunteers
  • Substances:Measles Virus Edmonston-Enders Strain (Live, Attenuated) Produced In Chick Embryo Cells
  • Sponsor:Rijksinstituut voor Volksgezondheid en Milieu (RIVM)

Pneumococcal immunisation

Not recruiting

Study of 20-valent pneumococcal conjugate vaccine (PCV20) booster response in healthy adults aged 78-84 years

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:65+ years · Healthy volunteers
  • Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
  • Sponsor:Rijksinstituut voor Volksgezondheid en Milieu (RIVM)

Respiratory syncytial virus infection+1

Not recruiting

Studying the Effect of Nirsevimab Immunization on Antibody Development After RSV Infection in Healthy Infants

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · Healthy volunteers
  • Substances:Nirsevimab
  • Sponsor:Rijksinstituut voor Volksgezondheid en Milieu (RIVM)

Influenza

Not recruiting

Study on the Best Time for Influenza Vaccine Administration in Adults Aged 60-85 Using Influenza Vaccine and Drug Combination

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type)
  • Sponsor:Rijksinstituut voor Volksgezondheid en Milieu (RIVM)

Meningococcal immunisation

Not recruiting

Study on Immune Response to Meningococcal Vaccine in Elderly with Invasive Meningococcal Disease Using MenACWY-TT Conjugate Vaccine

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:65+ years · Healthy volunteers
  • Substances:N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
  • Sponsor:Rijksinstituut voor Volksgezondheid en Milieu (RIVM)

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.